
November 2025 saw the launch of BIRSA 101- India’s first indigenous CRISPR-based gene therapy for sickle cell disease. What does this mean for affordable gene therapy, disease reduction and the research ecosystem in India? Shambhavi Naik explains some interesting aspects of this in this conversation with Suman Joshi.
Check out Takshashila's brand-new offering - an Expert Capsule Course on the Politics and Policy of Critical Minerals. Early-bird applications close April 12th - school.takshashila.org.in/politics-and-policy-of-critical-minerals
All Things Policy is a daily podcast on public policy brought to you by the Takshashila Institution, Bengaluru.Find out more on our research and other work here: https://takshashila.org.in/research-areas
Flere episoder fra "All Things Policy"



Gå ikke glip af nogen episoder af “All Things Policy” - abonnér på podcasten med gratisapp GetPodcast.








